Rett Syndrome Completed Phase 2 / 3 Trials for Blarcamesine (DB05592)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04304482ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeTreatment